摘要
目的研究复方血栓通胶囊治疗中浆的临床疗效及安全性。方法选择2011年3月—2014年3月来我院眼科就诊的110例中浆患者,随机分为两组,每组55例,对照组给予单纯激光光凝治疗;实验组给予复方血栓通胶囊联合激光光凝治疗。治疗2个月后观察总体疗效和复发率。结果治疗2个月后实验组总有效率为94.55%,显著高于对照组的70.91%,差异具有统计学意义(P<0.05)。治疗2个月和1年后,实验组发生荧光渗漏患者分别占总例数的1.82%和3.64%,显著低于对照组的12.73%和16.36%,差异具有统计学意义(P<0.05)。两组均无明显不良反应发生。结论复方血栓通胶囊联合激光光凝能显著改善中浆患者视力,提高治疗总有效率,降低复发率,且安全性高,临床应用价值高,值得推广。
Objective To study the clinical effect and safety of compound Xueshuantong capsule in the treatment of central serous chorioretinopathy. Methods Selecting 110 cases of patients with central serous chorioretinopathy in our hospital from March 2011 to March 2014, they were randomly assigned to two groups, with 55 cases in each group. Patients in the control group were treated by laser photocoagulation treatment. The experimental group was given compound Xueshuantong capsule combined with laser photocoag-ulation treatment. After 2 months of treatment, the overall effect and recurrence rate were observed. Results After two months＇ treatment, the total effective rate of the experimental group was 94.55 % which was significantly higher than 70.91% of the control group,and the difference was statistically significant（ P〈0.05）. 2 months and 1 year after treatment, 3.64% and 1.82% of the total number of patients in the experimental group had Fluorescent leakage, which were significantly lower than 12.73 % and 16.36% of the control group, and the difference was statistically significant（ P〈0.05）. No obvious adverse reactions occurred in the two groups.Conclusion Compound Xueshuantong capsule combined with laser photocoagulation in the treatment of central serous chorioretinopa-thy can significantly improve the vision of serous chorioretinopathy patients, improve the total effective rate, and reduce the recur-rence rate. It has the advantages of high safety and high clinical application value. It is worthy of promotion.
出处
《中国中医药现代远程教育》
2016年第9期83-84,共2页
Chinese Medicine Modern Distance Education of China
关键词
中浆
复方血栓通胶囊
激光光凝
central serous chorioretinopathy
compound Xueshuantong capsule
laser photocoagulation
